Clinical Trial Update: Next Generation Ingestible Sensors for Medication Adherence Measurement [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating next-generation ingestible sensors to measure HIV medication adherence has completed, with no efficacy results included in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: HIV Infection, Adherence, Medication | Phase 3 | Status: COMPLETED